Dermatology Doctors in Paoli, PA Accepting Medicare

4 Dermatology doctors found. Showing 1 - 4

Shelley Sue Schuler, M.D. Dermatology - Procedural Dermatology Medicare: Not Enrolled in Medicare Practice Location: 21 Industrial Blvd Ste 101, Paoli, PA 19301 Phone: 610-647-4161    Fax: 610-647-5397

Dr. Maria Madelyn Hannaway, MD Dermatology Medicare: Medicare Enrolled Practice Location: 21 Industrial Blvd Ste 101, Paoli, PA 19301 Phone: 610-647-4161

James J Ko, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 4 Industrial Blvd Suite 200, Paoli, PA 19301 Phone: 610-566-7111

Donna Jane Mackay, M.D., PH.D. Dermatology - Procedural Dermatology Medicare: Medicare Enrolled Practice Location: 21 Industrial Blvd Ste 101, Paoli, PA 19301 Phone: 610-647-4161    Fax: 610-647-5397

News Archive

Combination of HUCBCs and Simvastatin offers promising therapy for stroke: Study

Researchers at the Henry Ford Health System (Detroit, MI) and colleagues at Saneron CCEL Therapeutics, Inc. of Tampa, Florida, have found that when human umbilical cord blood cells were transplanted into test rats modeled with stroke, the addition of Simvastatin to the HUCBCs significantly increased the therapeutic benefit of the HUCBCs.

Early HAART during TB treatment prolongs survival of untreated HIV-infected adults: CAMELIA study

A clinical trial in Cambodia has found it possible to prolong the survival of untreated HIV-infected adults with very weak immune systems and newly diagnosed tuberculosis (TB) by starting anti-HIV therapy two weeks after beginning TB treatment, rather than waiting eight weeks, as has been standard.

With Minn. budget talks stalled, social services make funding plea

A state district court has ordered programs essential to life, health and public safety to continue during the shutdown. A judge is now holding hearings and will make recommendations about which programs fall into this category.

CASI Pharmaceuticals receives $10.3 million in strategic financing

CASI Pharmaceuticals, Inc., a biopharmaceutical company dedicated to innovative therapeutics addressing cancer and other unmet medical needs, announces it has received approximately $10.3 million in a strategic financing previously announced on September 21, 2015.

Read more Medical News

› Verified 7 days ago